KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Emergent BioSolutions (EBS) Other Non Operating Income: 2010-2025

Historic Other Non Operating Income for Emergent BioSolutions (EBS) over the last 16 years, with Sep 2025 value amounting to -$3.7 million.

  • Emergent BioSolutions' Other Non Operating Income fell 116.89% to -$3.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $59.0 million, marking a year-over-year increase of 120.15%. This contributed to the annual value of $12.5 million for FY2024, which is 40.45% up from last year.
  • Emergent BioSolutions' Other Non Operating Income amounted to -$3.7 million in Q3 2025, which was down 0.00% from -$3.7 million recorded in Q2 2025.
  • In the past 5 years, Emergent BioSolutions' Other Non Operating Income registered a high of $69.7 million during Q1 2025, and its lowest value of -$13.4 million during Q3 2022.
  • Moreover, its 3-year median value for Other Non Operating Income was -$3.3 million (2024), whereas its average is $7.6 million.
  • In the last 5 years, Emergent BioSolutions' Other Non Operating Income tumbled by 458.33% in 2022 and then surged by 2,150.00% in 2025.
  • Emergent BioSolutions' Other Non Operating Income (Quarterly) stood at -$900,000 in 2021, then soared by 844.44% to $6.7 million in 2022, then soared by 64.18% to $11.0 million in 2023, then slumped by 130.00% to -$3.3 million in 2024, then tumbled by 116.89% to -$3.7 million in 2025.
  • Its Other Non Operating Income stands at -$3.7 million for Q3 2025, versus -$3.7 million for Q2 2025 and $69.7 million for Q1 2025.